Capecitabine Tablets

Product/Composition Capecitabine Tablets
Strength 500mg
Form Tablets
Production Capacity 10 Million Tablets/Month
Packaging 1 X 10 Tablets / Box
Therapeutic use Anti Cancer
Package Insert/Leaflet Available upon request

Capecitabine Tablets

Category: Antimetabolite / Oral chemotherapy
Form: Oral tablets

Uses:

  • Treatment of breast cancer (especially after failure of other chemotherapy or in metastatic cases).

  • Treatment of colorectal cancer, including adjuvant therapy after surgery and metastatic disease.

  • Sometimes used in combination with other chemotherapy drugs (e.g., oxaliplatin, docetaxel).

Mechanism of Action:

  • Capecitabine is a prodrug that is converted in the body to 5-fluorouracil (5-FU).

  • 5-FU interferes with DNA synthesis by inhibiting the enzyme thymidylate synthase, preventing cancer cell replication.

  • Selectively activated in tumor tissue due to higher levels of certain enzymes, leading to more targeted action.

Administration:

  • Taken orally with food (usually within 30 minutes after a meal).

  • Given in treatment cycles, e.g., 2 weeks on treatment followed by 1 week off.

  • Dosage is based on body surface area, cancer type, and patient tolerance.

Side Effects:

  • Common: diarrhea, nausea, vomiting, loss of appetite, fatigue, abdominal pain.

  • Hand-foot syndrome (palmar-plantar erythrodysesthesia): redness, swelling, pain, or peeling of skin on palms and soles.

  • Hematologic: low white blood cells, low platelets, anemia.

  • Other: mouth sores, increased liver enzymes, rash.

  • Rare but serious: severe diarrhea, heart problems (e.g., chest pain, arrhythmias), severe infections due to low immunity.

Precautions:

  • Not recommended during pregnancy or breastfeeding due to risk of fetal harm.

  • Kidney function should be checked, as dose adjustments may be needed in renal impairment.

  • Careful monitoring of blood counts and liver function during treatment.

  • Patients should maintain good hydration and report early signs of severe diarrhea or hand-foot syndrome.

Summary:
Capecitabine Tablets are an oral chemotherapy drug used mainly in breast and colorectal cancers. It works as a prodrug of 5-FU, interfering with DNA synthesis in cancer cells. Taken in cycles, it allows outpatient treatment but requires careful monitoring. The most notable side effects are hand-foot syndrome, diarrhea, and bone marrow suppression, which may require dose adjustments.